SI9420016B - Enantioselektivna sinteza 5,6 -dihidro-(S)-4-(etilamino)-(S)-6-metil-4H-tieno /2,3-b/ tiopiran-2- sulfonamid 7,7- dioksida in sorodnih spojin - Google Patents

Enantioselektivna sinteza 5,6 -dihidro-(S)-4-(etilamino)-(S)-6-metil-4H-tieno /2,3-b/ tiopiran-2- sulfonamid 7,7- dioksida in sorodnih spojin Download PDF

Info

Publication number
SI9420016B
SI9420016B SI9420016A SI9420016A SI9420016B SI 9420016 B SI9420016 B SI 9420016B SI 9420016 A SI9420016 A SI 9420016A SI 9420016 A SI9420016 A SI 9420016A SI 9420016 B SI9420016 B SI 9420016B
Authority
SI
Slovenia
Prior art keywords
compound
acid
methyl
treating
iii
Prior art date
Application number
SI9420016A
Other languages
English (en)
Other versions
SI9420016A (en
Inventor
Paul Sohar
David J. Mathre
Thomas J. Blacklock
Original Assignee
Merck & Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co., Inc. filed Critical Merck & Co., Inc.
Publication of SI9420016A publication Critical patent/SI9420016A/sl
Publication of SI9420016B publication Critical patent/SI9420016B/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Seasonings (AREA)

Claims (8)

  1. PATENTNI ZAHTEVKI 1. Postopek za pripravo spojine s strukturno formulo I: NH
    I in njene hidrokloridne soli, pri čemer je kiralnost pri C-6 fiksna in je trans-s tereokemična povezava med C-4 in C-6 substituenti ohranjena, spojina je kristalinična in R in R1 sta enaka ali različna in sta alkil, ki obsega stopnje: A) obdelovanje spojine s formulo II z HO
    o2 II R» nitrilom s formulo RCN in količina prisotne vode, v kisline, od 0,5 do 10 mas strukturo III: močno kislino, tako da je odvisnosti od uporabljene %, da se tvori spojina s -2- R Ο
    R1 ΝΗ
    III \ ο. Β) obdelovanje spojine III s klorosulfonsko kislino, da se tvori spojina s strukturo IV: O A NH
    C) obdelovanje spojine IV s tionilovim kloridom, da se tvori spojina s strukturo V: O NH SO?CI Γϊν R1^s-^s o, D) obdelovanje spojine V z amoniakom, da se tvori spojina s strukturo VI:
    VI -3- E) obdelovanje spojine VI z natrijevim borohidridom in močno kislino ali boran-tetrahidrofuranom, da se tvori spojina s strukturo VII
    F) izolacija spojine VII kot maleatna sol VIII; G) pretvorba spojine VIII v hidrokloridno sol spojine I; in H) čiščenje hidrokloridne soli spojine I.
  2. 2. Postopek iz zahtevka 1, pri čemer sta R in R1 metil.
  3. 3. Postopek iz zahtevka 1, pri čemer je R metil in R1 n-propil.
  4. 4. Postopek za pripravo spojine s strukturno formulo III:
    III pri čemer je kiralnost pri C-6 fiksna in je trans-stereokemična -4- povezava med C-4 in C-6 substituenti ohranjena, R in R1 pa sta enaka ali različna in sta C1-3 alkil, ki obsega: obdelovanje spojine s formulo II z HO
    II nitrilom s formulo RCN in močno anorgansko kislino, tako da je količina prisotne vode, v odvisnosti od uporabljene kisline, od 0,5 do 10 mas. %.
  5. 5. Postopek iz zahtevka 4, pri čemer sta R in R1 metil.
  6. 6. Postopek iz zahtevka 4, pri čemer je R metil in R1 je n-propil.
  7. 7. Postopek iz zahtevka 1, pri čemer je močna kislina koncentrirana žveplova kislina ali zmes koncentrirane žveplove kisline in kadeče se žveplove kisline ali metansulfonska kislina, trifluoroocetna kislina ali borotrifluorid eterat in količina prisotne vode je od 1 do 2 mas. %.
  8. 8. Postopek iz zahtevka 1, pri čemer spojina s strukturno formulo I kristalizira po raztapljanju surove spojine s strukturno formulo I v vodni raztopini pri temperaturi 90 °C do 95 °C; po dodajanju aktivnega oglja, mešanju zmesi, filtriranju zmesi skozi plast filtrirnega pomožnega sredstva, izpiranju filtrskega kolača z vročo vodno raztopino, kombiniranju filtrata in kolača, kristaliziranju spojine s strukturno formulo I, ko se raztopina ohladi na 1 °C do 5 °C, filtriranju zmesi, zbiranju kolača in sušenju kolača. Za Merck & Co., Inc. Rahway New Jersey 07065-0900 ZDA : ODVETNICA ALEKSANDRA JANEŽIČ Ljubljana, Resljeva c. 24 teL; 300 76 60, tar433 70 98
SI9420016A 1993-03-22 1994-03-16 Enantioselektivna sinteza 5,6 -dihidro-(S)-4-(etilamino)-(S)-6-metil-4H-tieno /2,3-b/ tiopiran-2- sulfonamid 7,7- dioksida in sorodnih spojin SI9420016B (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3552393A 1993-03-22 1993-03-22
US19588694A 1994-02-10 1994-02-10
PCT/US1994/002852 WO1994021645A1 (en) 1993-03-22 1994-03-16 ENANTIOSELECTIVE SYNTHESIS OF 5,6-DIHYDRO-(S)-4-(ETHYLAMINO)-(S)-6-METHYL-4H-THIENO[2,3-b]THIOPYRAN-2-SULFONAMIDE 7,7-DIOXIDE AND RELATED COMPOUNDS

Publications (2)

Publication Number Publication Date
SI9420016A SI9420016A (en) 1996-06-30
SI9420016B true SI9420016B (sl) 2002-12-31

Family

ID=26712200

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9420016A SI9420016B (sl) 1993-03-22 1994-03-16 Enantioselektivna sinteza 5,6 -dihidro-(S)-4-(etilamino)-(S)-6-metil-4H-tieno /2,3-b/ tiopiran-2- sulfonamid 7,7- dioksida in sorodnih spojin

Country Status (29)

Country Link
US (1) US5688968A (sl)
EP (1) EP0617037B1 (sl)
JP (1) JP3273096B2 (sl)
KR (1) KR0157162B1 (sl)
CN (1) CN1046732C (sl)
AT (1) ATE163291T1 (sl)
AU (1) AU673409B2 (sl)
BR (1) BR9406017A (sl)
CA (1) CA2119218C (sl)
CY (1) CY2108B1 (sl)
CZ (1) CZ281390B6 (sl)
DE (1) DE69408550T2 (sl)
DK (1) DK0617037T3 (sl)
ES (1) ES2112482T3 (sl)
FI (1) FI107384B (sl)
GR (1) GR3026178T3 (sl)
HK (1) HK1009063A1 (sl)
HR (1) HRP940182B1 (sl)
HU (1) HU217363B (sl)
NO (1) NO313240B1 (sl)
NZ (1) NZ263092A (sl)
PL (1) PL176373B1 (sl)
RO (1) RO115264B1 (sl)
SI (1) SI9420016B (sl)
SK (1) SK280831B6 (sl)
TW (1) TW265343B (sl)
UA (1) UA41921C2 (sl)
WO (1) WO1994021645A1 (sl)
YU (1) YU48951B (sl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5760249A (en) * 1995-08-29 1998-06-02 Merck & Co., Inc. Synthesis of hydroxysulfone and related compounds
ES2177415B1 (es) * 2000-09-04 2004-10-16 Ragactives, S.L. Procedimiento para la obtencion de 4-alquilamino-5, 6-dihidro-4h-tieno-(2,3b)-tiopiran-2-sulfonamida-7-dioxidos, e intermedios.
ES2204306B1 (es) * 2002-08-16 2005-08-01 Ragactives, S.L. Formas polimorficas de clorhidrato de dorzolamida, su obtencion y composiciones farmaceuticas que las contienen.
US7053115B2 (en) * 2003-04-07 2006-05-30 Hetero Drugs Limited Crystalline form of dorzolamide hydrochloride
EP1765828B1 (en) * 2004-07-09 2007-12-05 FDC Limited AN IMPROVED PROCESS FOR THE PREPARATION OF 5,6 -DIHYDRO -4H-4(S)-ETHYLAMINO-6(S)-METHYLTHIENO[2,3-b] THIOPYRAN-2-SULFONAMIDE- 7,7 -DIOXIDE AND ITS SALT
ES2253112B1 (es) * 2004-11-05 2007-03-16 Ragactives, S.L. Procedimiento para la obtencion de derivados de 4-(n-alquilamino)-5, 6-dihidro-4h-tieno-(2,3-b)-tiopirano.
WO2006070387A1 (en) * 2004-12-28 2006-07-06 Council Of Scientific And Industrial Research PROCESS FOR PREPARING 5,6-DIHYDRO-4-(S)-(ETHYLAMINO)-6-(S) METHYL-4H-THIENO[2,3b]THIOPYRAN-2-SULPHONAMIDE-7,7-DIOXIDE HCI
US7109353B2 (en) 2004-12-28 2006-09-19 Council Of Scientific And Industrial Research Process for preparing 5,6-dihydro-4-(S)-(ethylamino)-6-(S) methyl-4H-thieno[2,3b]thiopyran-2-sulphonamide-7,7-dioxide HCl
CN101098874A (zh) * 2005-01-06 2008-01-02 特瓦药厂私人有限公司 制备盐酸多佐胺的方法
JP2008526780A (ja) * 2005-01-18 2008-07-24 テバ ジョジセルジャール ザ−トケルエン ムケド レ−スベニュタ−ルシャシャ−グ ドルゾルアミド塩酸塩の非晶質および結晶質の形態およびそれらを製造する方法
EP2152718A2 (en) 2007-05-07 2010-02-17 Cipla Limited Process for preparing dorzolamide
WO2012120086A1 (en) 2011-03-10 2012-09-13 Zach System S.P.A. Asymmetric reduction process
ITMI20121165A1 (it) * 2012-07-03 2014-01-04 Zach System Spa Processo di riduzione asimmetrica
CN105636444B (zh) * 2013-10-17 2018-04-27 美国陶氏益农公司 制备杀虫化合物的方法
CA2925953C (en) * 2013-10-17 2021-11-02 Dow Agrosciences Llc Processes for the preparation of pesticidal compounds
CN103497202B (zh) * 2013-10-23 2015-12-02 武汉武药科技有限公司 盐酸多佐胺中间体的合成方法
CN108822127B (zh) * 2018-05-30 2020-05-15 沈阳药科大学 4-羟亚胺基噻吩并[2,3-b]噻喃-2-甲酰胺类化合物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863922A (en) * 1984-12-12 1989-09-05 Merck & Co., Inc. Substituted aromatic sulfonamides as antiglaucoma agents, compositions and use
US4797413A (en) * 1986-05-14 1989-01-10 Merck & Co., Inc. Thieno thiopyran sulfonamide derivatives, pharmaceutical compositions and use
US4968814A (en) * 1990-04-18 1990-11-06 Merck & Co., Inc. (S)-Alkyl 3-(thien-2-ylthio)butyrate and analogs and synthesis thereof
US5091409A (en) * 1990-05-17 1992-02-25 Merck & Co., Inc. 4-alkylamino-6-(C3-5 -hydrocarbyl)thieno[2,3-B]thiopyran-2-sulfonamide-7,7-dioxides

Also Published As

Publication number Publication date
CA2119218A1 (en) 1994-09-23
KR0157162B1 (ko) 1998-11-16
ATE163291T1 (de) 1998-03-15
SK280831B6 (sk) 2000-08-14
DK0617037T3 (da) 1998-03-16
AU5787194A (en) 1994-09-29
NO313240B1 (no) 2002-09-02
EP0617037B1 (en) 1998-02-18
US5688968A (en) 1997-11-18
NZ263092A (en) 1997-12-19
CA2119218C (en) 2000-02-15
EP0617037A1 (en) 1994-09-28
PL310633A1 (en) 1995-12-27
SI9420016A (en) 1996-06-30
YU48951B (sh) 2003-01-31
TW265343B (sl) 1995-12-11
CY2108B1 (en) 2002-04-26
BR9406017A (pt) 1995-12-19
PL176373B1 (pl) 1999-05-31
HUT72676A (en) 1996-05-28
HU217363B (hu) 2000-01-28
FI107384B (fi) 2001-07-31
GR3026178T3 (en) 1998-05-29
CZ241895A3 (en) 1996-01-17
CZ281390B6 (cs) 1996-09-11
CN1119866A (zh) 1996-04-03
JP3273096B2 (ja) 2002-04-08
DE69408550D1 (de) 1998-03-26
NO953733D0 (no) 1995-09-21
WO1994021645A1 (en) 1994-09-29
RO115264B1 (ro) 1999-12-30
UA41921C2 (uk) 2001-10-15
SK116995A3 (en) 1997-06-04
HU9502772D0 (en) 1995-11-28
FI954438A (fi) 1995-09-20
HK1009063A1 (en) 1999-05-21
NO953733L (no) 1995-09-21
DE69408550T2 (de) 1998-08-27
HRP940182B1 (en) 2000-02-29
ES2112482T3 (es) 1998-04-01
YU13194A (sh) 1997-01-08
JPH06298767A (ja) 1994-10-25
CN1046732C (zh) 1999-11-24
FI954438A0 (fi) 1995-09-20
AU673409B2 (en) 1996-11-07
HRP940182A2 (en) 1996-08-31

Similar Documents

Publication Publication Date Title
SI9420016B (sl) Enantioselektivna sinteza 5,6 -dihidro-(S)-4-(etilamino)-(S)-6-metil-4H-tieno /2,3-b/ tiopiran-2- sulfonamid 7,7- dioksida in sorodnih spojin
SU929009A3 (ru) Способ получени бензофуранил-бензимидазолов
SU645571A3 (ru) Способ получени производных хиназолона или их солей
Cornforth et al. 24. A new synthesis of oxazoles and iminazoles including its application to the preparation of oxazole
CA1073911A (en) Antimicrobial bis-pyridinium compounds
DE3060551D1 (en) 2-alkoxyphenyl-imidazo(4,5-b)pyridines, their preparation, their use in the production of medicaments and medicaments containing these compounds
CA1149809A (en) Isoquinoline derivatives and process for their preparation
FI64144B (fi) Foerfarande foer framstaellning av 2-arylamino-2-imidazolinderivat
SU629881A3 (ru) Способ получени производных тиазоло (3,4 - ) изохинолина или их оптических изомеров или их солей
Black et al. Synthetic studies related to mycobactins. I. Synthesis of 2-(2'-hydroxyphenyl)-2-oxazoline-4-carboxylic acid and related compounds
PT887350E (pt) Novos derivados cromenicos processo para a sua preparacao e composicoes farmaceuticas que os contem
PL117046B1 (en) Process for the preparation of thienopyridine derivatives
Elgemeie et al. Reaction of (Cyano) thioacetamide with Arylhydrazones of. BETA.-Diketones: Novel Synthesis of 2 (1H)-Pyridinetiones, Thieno (2, 3-b) pyridines, and Pyrazolo (3, 4-b) pyridines.
NO20004580L (no) Kjemisk fremgangsmÕte for fremstilling av sulfinylderivater ved oksydasjon av de tilsvarende CO-derivater med perborater
SI9111975B (en) Novel derivatives of 3,4-dihydroisoquinoline, processes for their preparation and pharmaceutical compositions containing novel compounds
JPS5940155B2 (ja) 4−オキソヘキサヒドロピラジノイソキノリン誘導体の製造方法
JPS5931514B2 (ja) 4,5,6,7−テトラヒドロ−チエノ〔3,2−c〕ピリジン誘導体およびその製造方法
PT1678182E (pt) Processo para preparar 5-amino-pirazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pirimidinas
FR2544718A1 (fr) Diniflumate d'ester morpholinoethylique d'acide niflumique, preparation, utilisation en therapeutique comme analgesique et anti-inflammatoire
Boyd et al. Sulfonic Acid Esters as Alkylating Agents: Formation of 2-Oxazolines1
PL95005B1 (sl)
US4034103A (en) Aralkylamino sulfones having spasmolytic activities
HRP20000027B1 (en) Process for the preparation of alkoxyfuranoneamine derivatives, compounds obtained by this process, and the use of these compounds
ATE5820T1 (de) 5-substituierte 9-cyanmethylen-dithieno(3,4b:4'.3'-e)-azepine, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel.
US4042693A (en) Derivatives of 1,2,4-thiadiazine

Legal Events

Date Code Title Description
IF Valid on the event date
SP73 Change of data on owner

Owner name: MERCK SHARP & DOHME CORP.; US

Effective date: 20021015

SP73 Change of data on owner

Owner name: MERCK SHARP & DOHME CORP.; US

Effective date: 20121127